For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

A Medicare pilot program could expand access to GLP-1 weight-loss drugs for millions of seniors while lowering monthly costs ...

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

Serco Awarded $109 Million CMS CERT Contract, Extending Support of Medicare Program Integrity The CMS CERT program is a vital ...